IP
NUVB icon

Intellectus Partners’s Nuvation Bio NUVB Stock Holding History

Intellectus Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
293,417
+3,000
+1% +$14.7K 0.29% 90
2026
Q1 		$1.25M Buy
290,417
+5,000
+2% +$27.9K 0.25% 111
2025
Q4 		$2.56M Sell
285,417
-46,388
-14% -$287K 0.49% 49
2025
Q3 		$1.23M Buy
331,805
+2,000
+0.6% +$5.45K 0.24% 110
2025
Q2 		$643K Buy
329,805
+8,900
+3% +$18.5K 0.14% 174
2025
Q1 		$565K Buy
320,905
+40,000
+14% +$91.1K 0.14% 179
2024
Q4 		$747K Buy
280,905
+19,500
+7% +$50.2K 0.17% 159
2024
Q3 		$599K Buy
261,405
+14,500
+6% +$44.2K 0.15% 175
2024
Q2 		$721K Buy
246,905
+12,465
+5% +$38K 0.2% 143
2024
Q1 		$853K Buy
234,440
+53,318
+29% +$102K 0.22% 128
2023
Q4 		$273K Sell
181,122
-19,105
-10% -$24.6K 0.08% 210
2023
Q3 		$268K Buy
200,227
+698
+0.3% +$1.16K 0.08% 213
2023
Q2 		$359K Buy
199,529
+17,860
+10% +$30.4K 0.11% 203
2023
Q1 		$302K Sell
181,669
-1,500
-0.8% -$3.04K 0.1% 203
2022
Q4 		$352K Buy
183,169
+9,223
+5% +$18.7K 0.12% 194
2022
Q3 		$390K Buy
173,946
+12,680
+8% +$36.2K 0.14% 180
2022
Q2 		$523K Buy
161,266
+12,192
+8% +$53.2K 0.18% 158
2022
Q1 		$784K Buy
149,074
+8,752
+6% +$49.2K 0.23% 110
2021
Q4 		$1.19M Sell
140,322
-14,105
-9% -$130K 0.3% 86
2021
Q3 		$1.53M Buy
154,427
+33,995
+28% +$308K 0.37% 71
2021
Q2 		$1.12M Buy
120,432
+21,008
+21% +$240K 0.25% 109
2021
Q1 		$1.04M Sell
99,424
-32,520
-25% -$364K 0.29% 109
2020
Q4 		$1.54M Buy
+131,944
New +$1.37M 0.46% 62

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Intellectus Partners's NUVB Position: Q2 2026 in Review

Intellectus Partners increased its Nuvation Bio (NUVB) stake by 1% in Q2 2026, buying an estimated $14.7K and bringing the position to 293,417 shares worth $1.67M. The position accounts for 0.29% of the portfolio, ranked #90.

Intellectus Partners first reported a position in NUVB in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.56M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Intellectus Partners held 293,417 shares of Nuvation Bio worth $1.67M as of Q2 2026.
  • Intellectus Partners bought 3,000 Nuvation Bio shares in Q2 2026, an estimated $14.7K.
  • Nuvation Bio made up 0.29% of Intellectus Partners's portfolio in Q2 2026, its #90 holding.
  • Intellectus Partners first reported a position in Nuvation Bio in Q4 2020 and has held it in 23 quarters since.
  • Intellectus Partners's Nuvation Bio position peaked at $2.56M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.